Abstract:Background Long intergenic non-protein coding RNA 1140 (LINC01140), a long non-coding RNA, is highly expressed in various cancers; however, its biological functions in lung cancer (LC) progression and immune escape are still unclear. Methods Here, to elucidate LINC01140 function, 79 paired LC and paracancerous tissues were collected. LINC01140 expression levels were determined using fluorescence in situ hybridization and qPCR analysis. Cell counting kit-8 (CCK-8) assay and transwell assays were performed. The interaction between microRNAs (miRNAs) and LINC01140 was confirmed using an RNA immunoprecipitation assay. Cytokine-induced killer (CIK) cell phenotypes were analyzed by flow cytometry. Cytokine secretion levels were determined by ELISA. CIK cytotoxicity was assessed by measuring lactate dehydrogenase release. Besides, xenograft tumor mouse models were used to unveil the in vivo function of LINC01140. Results We found that LINC01140 was highly expressed in human LC tissues and cell lines. High LINC01140 levels were associated with poor survival in patients with LC. LINC01140 upregulation promoted the proliferation, migration, and invasion of LC cells through direct interaction with miR-33a-5p and miR-33b-5p, thereby contributing to c-Myc expression and also inhibited cisplatin-induced cell apoptosis. In subcutaneous tumor xenograft mice, LINC01140 knockdown markedly reduced tumor growth and lung metastasis. Additionally, LINC01140 directly repressed miR-377-3 p and miR-155-5 p expression levels, resulting in the upregulation of their common downstream target programmed death-ligand 1 (PD-L1), a crucial target in LC immunotherapy. Notably, we proved that LINC01140 knockdown, along with CIK administration, suppressed the growth of subcutaneous LC xenografts by decreasing PD-L1 expression in severe combined immunodeficient mice. Conclusions Taken together, LINC01140 overexpression protects c-Myc and PD-L1 mRNA from miRNA-mediated inhibition and contributes to the proliferation, migration, invasion, and immune escape of LC cells. These results provide a theoretical basis that LINC01140 is a promising target for LC treatment.

LINC00891 Regulated by Mir-128-3p/gata2 Axis Impedes Lung Cancer Cell Proliferation, Invasion and EMT by Inhibiting RhoA Pathway.

Long Noncoding RNA LINC01426 Promotes the Progression of Lung Adenocarcinoma Via Regulating Mirna-125A-5p/ Casein Kinase 2 Alpha 1 Axis

LINC01207 Promotes the Progression of Non-Small Cell Lung Cancer Via Regulating ARHGAP11A by Sponging Mir-525-5p

Downregulated long intergenic non-coding RNA 00,174 represses malignant biological behaviors of lung cancer cells by regulating microRNA-584-3p/ribosomal protein S24 axis

Long Noncoding RNA LINC00520 Accelerates Lung Adenocarcinoma Progression Via Mir-1252-5p/foxr2 Pathway

Long Noncoding RNA LINC00518 Contributes to Proliferation and Metastasis in Lung Adenocarcinoma Via the Mir-335-3p/cthrc1 Axis

Dysregulated <i>LINC00961</i> Contributes to the Vitality and Migration of NSCLC Via miR-19a-3p/miR-19b-3p/miR-125b-5p

LINC00968 Can Inhibit the Progression of Lung Adenocarcinoma Through the Mir-21-5p/smad7 Signal Axis.

Long noncoding RNA LINC00961 inhibits cell invasion and metastasis in human non-small cell lung cancer.

LINC81507 act as a competing endogenous RNA of miR-199b-5p to facilitate NSCLC proliferation and metastasis via regulating the CAV1/STAT3 pathway

Downregulation of LINC01296 Suppresses Non-Small-cell Lung Cancer Via Targeting Mir-143-3p/atg2b.

A Novel Long Non-Coding RNA LINC00355 Promotes Proliferation of Lung Adenocarcinoma Cells by Down-Regulating Mir-195 and Up-Regulating the Expression of CCNE1.

Linc00958 Promotes Lung Cancer Proliferation and Migration Through Regulating microRNA-490-3p

LINC00511 Promotes Lung Squamous Cell Carcinoma Proliferation and Migration Via Inhibiting Mir-150-5p and Activating TADA1

LINC01140 promotes the progression and tumor immune escape in lung cancer by sponging multiple microRNAs

Linc00467 Promotes Lung Adenocarcinoma Proliferation Via Sponging Mir-20B-5p to Activate CCND1 Expression.

Downregulation of LINC00665 Confers Decreased Cell Proliferation and Invasion Via the Mir-138-5p/e2f3 Signaling Pathway in NSCLC.

LINC00943 Regulates Mir-1252-5p/ywhah Axis to Promote Tumor Proliferation and Metastasis in Lung Adenocarcinoma

Non-coding RNA LINC00857 is predictive of poor patient survival and promotes tumor progression via cell cycle regulation in lung cancer

Long Noncoding RNA LINC01296 Induces Non-Small Cell Lung Cancer Growth and Progression Through Sponging Mir-5095

Long Non-coding RNA LINC00628 Interacts Epigenetically with the LAMA3 Promoter and Contributes to Lung Adenocarcinoma